Immune Checkpoint Inhibitors in Cancer Therapy
The discovery of immune checkpoint proteins such as PD-1/PDL-1 and CTLA-4 represents a significant breakthrough in the field of cancer immunotherapy. Therefore, humanized monocl...
The discovery of immune checkpoint proteins such as PD-1/PDL-1 and CTLA-4 represents a significant breakthrough in the field of cancer immunotherapy. Therefore, humanized monocl...
<title>Abstract</title> Immune-checkpoint inhibitors (ICIs) are the primary treatment for advanced cutaneous squamous cell carcinoma (cSCC). Tumour microenvironment differences ...
h-index: Number of publications with at least h citations each.